ABBV LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving AbbVie Inc. Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds ABBV Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf Pharmaceutical Investing
DEADLINE ALERT for ABBV, MYPS, SDIG, and LICY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Reminds AbbVie, Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
ABBV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 6, 2022 in the Class Action Filed on Behalf of AbbVie Inc. Limited Shareholders Pharmaceutical Investing
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months Pharmaceutical Investing
Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 Pharmaceutical Investing
European Commission Approves Merck's KEYTRUDA® for Patients With Microsatellite Instability-High or Deficient Mismatch Repair Tumors in Five Different Types of Cancer Life Science Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
